FDA Clearance Tracker · P120006
OVATION ABDOMINAL STENT GRAFT SYSTEM
Last checked: Nov 20, 2026Latest source record: Oct 5, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Oct 5, 2012
Approved
Time to decision
177 days
Received Apr 11, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P120006
- Device name
- OVATION ABDOMINAL STENT GRAFT SYSTEM
- Applicant
- Endologix, LLC
- Applicant location
- Santa Rosa, CA
- Received
- Apr 11, 2012
- Decided
- Oct 5, 2012
- Decision
- Approved
- Supplements
- 38 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE OVATION ABDOMINAL STENT GRAFT SYSTEM. THIS DEVICE IS INDICATED FOR TREATMENT OF PATIENTS WITH ABDOMINALAORTIC ANEURYSMS HAVING VASCULAR MORPHOLOGY SUITABLE FOR ENDOVASCULAR REPAIR, INCLUDING: 1) ADEQUATE ILIAC/FEMORAL ACCESS COMPATIBLE WITH VASCULAR ACCESS TECHNIQUES, DEVICES, AND/OR ACCESSORIES; 2) NON-ANEURYSMAL PROXIMAL AORTIC NECK: A) WITH A LENGTH OF AT LEAST 7 MM PROXIMAL TO THE ANEURYSM; B) WITH AN INNER WALL DIAMETER OF NO LESS THAN 16 MM AND NO GREATER THAN 30 MM; AND C) WITH AN AORTIC ANGLE OF <= 60 DEGREES IF PROXIMAL NECK IS >= 10 MM AND <=45 DEGREES IF PROXIMAL NECK IS <10 MM. 3) ADEQUATE DISTAL ILIAC LANDING ZONE: A) WITH A LENGTH OF AT LEAST 10 MM; AND WITH AN INNER WALL DIAMETER OF NO LESS THAN 8 MM AND NO GREATER THAN 20 MM.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MIH. The earliest in FDA's data is P990017, decided Sep 28, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Endologix, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- DETOUR SystemBreakthroughPMA
P220021 · Decided Jun 7, 2023 · 239 days after receipt
Device type: Stent graft, bypass, superficial femoral artery (QWM) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.